StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

SPTX (SPTX)

Seaport Therapeutics, Inc. (SPTX) Misses Q3 EPS by 49c November 2, 2026 7:11 AM - StreetInsider Form 10-Q Seaport Therapeutics, For: Sep 30 November 2, 2026 7:09 AM - SEC Filing Form 8-K Seaport Therapeutics, For: Nov 02 November 2, 2026 7:04 AM - SEC Filing Seaport Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress November 2, 2026 7:00 AM - BizWire Seaport Therapeutics to Present at Stifel 2026 Healthcare Conference October 28, 2026 7:00 AM - BizWire Canaccord Starts Seaport Therapeutics (SPTX) at Buy October 14, 2026 5:14 AM - StreetInsider Seaport Therapeutics shares Phase 1 PK data for GlyphAgo at ECNP October 9, 2026 1:00 PM - StreetInsider PureTech Founded Entity Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress October 9, 2026 1:00 PM - BizWire Seaport Therapeutics shares Phase 1 PK data for GlyphAgo at ECNP October 9, 2026 7:00 AM - StreetInsider Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress October 9, 2026 7:00 AM - BizWire H.C. Wainwright Reiterates Buy Rating on Seaport Therapeutics (SPTX) October 8, 2026 7:04 AM - StreetInsider Seaport Therapeutics doses first patient in anxiety disorder trial October 7, 2026 1:00 PM - StreetInsider PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating GlyphAgo™ in Patients with Generalized Anxiety Disorder and Sleep Disturbance October 7, 2026 1:00 PM - BizWire Seaport Therapeutics doses first patient in GlyphAgo anxiety trial October 7, 2026 7:00 AM - StreetInsider Seaport Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating GlyphAgoTM in Patients with Generalized Anxiety Disorder and Sleep Disturbance October 7, 2026 7:00 AM - BizWire Raymond James Starts Seaport Therapeutics (SPTX) at Strong Buy September 25, 2026 6:06 AM - StreetInsider Seaport Therapeutics to Participate in September Investor Conferences September 14, 2026 7:00 AM - BizWire Seaport Therapeutics reports GlyphAllo shows no driving impairment September 9, 2026 7:01 AM - StreetInsider Jones Trading Starts Seaport Therapeutics (SPTX) at Buy August 25, 2026 4:17 PM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Seaport Therapeutics (SPTX) August 20, 2026 6:58 AM - StreetInsider Form SCHEDULE 13G Seaport Therapeutics, Filed by: PureTech LYT, Inc. August 14, 2026 4:35 PM - SEC Filing Seaport Therapeutics (SPTX) PT Lowered to $44 at JPMorgan August 5, 2026 8:17 AM - StreetInsider Form SCHEDULE 13G Seaport Therapeutics, Filed by: Zohar Daphne August 5, 2026 8:06 AM - SEC Filing Form SCHEDULE 13G Seaport Therapeutics, Filed by: PAUL STEVEN M August 5, 2026 6:06 AM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Seaport Therapeutics (SPTX) August 4, 2026 6:54 AM - StreetInsider Full Article List